Huifeng Bio-pharmaceutical Technology (fka HFGB)

[pappy]

Not really just trying to be conservative.

They did $0.06 in the 2nd qtr & $0.04 in the 1st with 25% more shares outstanding.

If they have eps of $0.06-$0.08 in the 3rd & 4th qtr that would bring 2010 eps in at $0.22-$0.26.

In 2009 eps was only $0.14 fully diluted so with the increased share count that is still a net income gain of over 100% from last year.

That is a o.k. conservative estimate in my opinion.

I haven't heard anything new about seeking listing other than their earlier statement,,,however the pps was close to $1.40 at that time.

The reason they were seeking listing was to raise more money for ambitous expanding.

I think they can grow at a nice clip from current growth so why be in a hurry to seek listing until the pps regains a more reasonable level.

I have a small position in NFEC that did a reverse to get listed.

The pps has been making new lows in spite getting new business so uplisting hasn't worked out to well for some Chinese stocks lately.